Microbiota: The Missing Link in the Etiology of Inflammatory Bowel Disease
Abstract
:Introduction
Discussions
IBD: Overview
Microbiota and IBD
Highlights
Conclusions
References
- Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem J. 2017, 474, 1823–1836. [Google Scholar] [CrossRef] [PubMed]
- Vancamelbeke, M.; Vermeire, S. The intestinal barrier: A fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017, 11, 821–834. [Google Scholar] [CrossRef]
- Rowland, I.; Gibson, G.; Heinken, A.; et al. Gut microbiota functions: Metabolism of nutrients and other food components. Eur J Nutr. 2018, 57, 1–24. [Google Scholar] [CrossRef]
- Blaut, M. Gut microbiota and energy balance: Role in obesity. Proc Nutr Soc. 2015, 74, 227–234. [Google Scholar] [CrossRef]
- Lazar, V.; Ditu, L.M.; Pircalabioru, G.G.; et al. Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer. Front Immunol. 2018, 9, 1830. [Google Scholar] [CrossRef] [PubMed]
- LeBlanc, J.G.; Milani, C.; de Giori, G.S.; Sesma, F.; van Sinderen, D.; Ventura, M. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr Opin Biotechnol. 2013, 24, 160–168. [Google Scholar] [CrossRef] [PubMed]
- De Luca, F.; Shoenfeld, Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019, 195, 74–85. [Google Scholar] [CrossRef]
- Pascal, M.; et al. Microbiome and Allergic Diseases; 2018. [Google Scholar] [CrossRef]
- Ma, J.; Li, H. The Role of Gut Microbiota in Atherosclerosis and Hypertension. Front Pharmacol. 2018, 9, 1082. [Google Scholar] [CrossRef]
- Dahmus, J.D.; Kotler, D.L.; Kastenberg, D.M.; Kistler, C.A. The gut microbiome and colorectal cancer: A review of bacterial pathogenesis. J Gastrointest Oncol. 2018, 9, 769–777. [Google Scholar] [CrossRef]
- Suceveanu, A.I.; Stoian, A.P.; Parepa, I.R.; Voinea, C.; Hainarosie, R.; Manuc, D.; Nitipir, C.; Mazilu, L.; Suceveanu, A.P. Gut Microbiota Patterns in Obese and Type 2 Diabetes (T2D) Patients from Romanian Black Sea Coast Region. CHIMIA (Bucharest). 2018, 69, 2260–2267. [Google Scholar] [CrossRef]
- Mazilu, L.; Ciufu, N.; Gălan, M.; Suceveanu, A.I.; Suceveanu, A.P.; Parepa, I.R.; Tofolean, D.E. Postherapeutic Follow-up of Colorectal Cancer Patients Treated with Curative Intent. Chirurgia 2012, 107, 55–58. [Google Scholar] [PubMed]
- Suceveanu, A.I.; Suceveanu, A.P.; Voinea, F.L.; Mazilu, L.; Mixici, F.; Adam, T. Introduction of cytogenetic tests in CRC screening. Introduction of cytogenetic tests in CRC screening. J Gastrointestin Liver Dis. 2009, 18, 33–38. [Google Scholar]
- Abraham, C.; Cho, J.H. Inflammatory Bowel Disease. N Engl J Med. 2009, 361, 2066–2078. [Google Scholar] [CrossRef] [PubMed]
- Hendrickson, B.A.; Gokhale, R.; Cho, J.H. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002, 15, 79–94. [Google Scholar] [CrossRef]
- Ng, S.C.; Shi, H.Y.; Hamidi, N.; et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2018, 390, 2769–2778. [Google Scholar] [CrossRef]
- Mozdiak, E.; O’Malley, J.; Arasaradnam, R. Inflammatory bowel disease. BMJ. 2015, 351, h4416. [Google Scholar] [CrossRef]
- Trifan, A.; et al. Gastroenterologie si Hepatologie Clinica. Editura Medicala (Bucharest). 2018, 288–311. [Google Scholar]
- Lane, E.R.; Zisman, T.L.; Suskind, D.L. The microbiota in inflammatory bowel disease: Current and therapeutic insights. J Inflamm Res. 2017, 10, 63–73. [Google Scholar] [CrossRef]
- Zuo, T.; Ng, S.C. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Front Microbiol. 2018, 9, 2247. [Google Scholar] [CrossRef]
- Macfarlane, G.T.; Blackett, K.L.; Nakayama, T.; Steed, H.; Macfarlane, S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009, 15, 1528–1536. [Google Scholar] [CrossRef]
- Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006, 55, 205–211. [Google Scholar] [CrossRef]
- Popoiag, R.E.; Pantea-Stoian, A.; Suceveanu, A.P.; Suceveanu, A.I.; Mazilu, L.; Parepa, I.R.; Serban, L.M.; Paunica, M.; Motofei, C.; Braticevici, C.F. The relationship between gut microbiota and spontaneous bacterial peritonitis in patients with liver cirrhosis—a literature review. J Mind Med Sci. 2019, 6, 26–30. [Google Scholar] [CrossRef]
- Sokol, H.; Seksik, P.; Furet, J.P.; et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009, 15, 1183–1189. [Google Scholar] [CrossRef]
- Frank, D.N.; Robertson, C.E.; Hamm, C.M.; et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011, 17, 179–184. [Google Scholar] [CrossRef]
- Kitajima, S.; Morimoto, M.; Sagara, E.; Shimizu, C.; Ikeda, Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim. 2001, 50, 387–395. [Google Scholar] [CrossRef] [PubMed]
- Stanescu, A.M.A.; Grajdeanu, I.V.; Iancu, M.A.; et al. Correlation of Oral Vitamin D Administration with the Severity of Psoriasis and the Presence of Metabolic Syndrome. Revista de chimie 2018, 69, 1668–1672. [Google Scholar] [CrossRef]
- Kennedy, R.J.; Hoper, M.; Deodhar, K.; Erwin, P.J.; Kirk, S.J.; Gardiner, K.R. Interleukin 10-deficient colitis: New similarities to human inflammatory bowel disease. Br J Surg. 2000, 87, 1346–1351. [Google Scholar] [CrossRef]
- Cao, S.S. Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2018, 2018, 7192646. [Google Scholar] [CrossRef]
- Sokol, H.; Leducq, V.; Aschard, H.; et al. Fungal microbiota dysbiosis in IBD. Gut. 2017, 66, 1039–1048. [Google Scholar] [CrossRef]
- Pérez-Brocal, V.; García-López, R.; Vázquez- Castellanos, J.F.; et al. Study of the viral and microbial communities associated with Crohn’s disease: A metagenomic approach. Clin Transl Gastroenterol. 2013, 4, e36. [Google Scholar] [CrossRef]
- Wagner, J.; Maksimovic, J.; Farries, G.; et al. Bacteriophages in gut samples from pediatric Crohn’s disease patients: Metagenomic analysis using 454 pyrosequencing. Inflamm Bowel Dis. 2013, 19, 1598–1608. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the author. 2020 Micu Ioan Sergiu, Manea Madalina Elena, Musat Marilena, Dumitru Andrada, Popoiag Roxana Emanuela
Share and Cite
Sergiu, M.I.; Elena, M.M.; Marilena, M.; Andrada, D.; Emanuela, P.R. Microbiota: The Missing Link in the Etiology of Inflammatory Bowel Disease. J. Mind Med. Sci. 2020, 7, 29-33. https://doi.org/10.22543/7674.71.P2933
Sergiu MI, Elena MM, Marilena M, Andrada D, Emanuela PR. Microbiota: The Missing Link in the Etiology of Inflammatory Bowel Disease. Journal of Mind and Medical Sciences. 2020; 7(1):29-33. https://doi.org/10.22543/7674.71.P2933
Chicago/Turabian StyleSergiu, Micu Ioan, Manea Madalina Elena, Musat Marilena, Dumitru Andrada, and Popoiag Roxana Emanuela. 2020. "Microbiota: The Missing Link in the Etiology of Inflammatory Bowel Disease" Journal of Mind and Medical Sciences 7, no. 1: 29-33. https://doi.org/10.22543/7674.71.P2933
APA StyleSergiu, M. I., Elena, M. M., Marilena, M., Andrada, D., & Emanuela, P. R. (2020). Microbiota: The Missing Link in the Etiology of Inflammatory Bowel Disease. Journal of Mind and Medical Sciences, 7(1), 29-33. https://doi.org/10.22543/7674.71.P2933